Endothelium-derived relaxing factor

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Endothelium-derived relaxing factor (EDRF) is a name for a substance Robert F. Furchgott discovered had the eponymous properties. Today, it is firmly established this substance is nitric oxide (NO).[1] Endothelium produces NO which then diffuses to the vascular smooth muscle tissue, although these seems to be evidence that vasodilatory may also be of neuronal origin, rather than endothelial.[2] NO is produced by the enzyme nitric oxide synthase and it relaxes smooth muscle tissue by promoting the synthesis of cGMP.[1]

Furchgott was a co-recipient of the 1998 Nobel Prize in Medicine with his colleagues Louis J. Ignarro and Ferid Murad. Shortly after his death in May 2009, Furchgott's website at SUNY Downstate Medical Center continued to state that his group was "investigating whether the endothelium-derived relaxing factor (EDRF) is simply nitric oxide or a mixture of substances".[3]

References[edit]

  1. ^ a b Francis, S. H.; Busch, J. L.; Corbin, J. D. (2010-09-01). "cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action". Pharmacological Reviews. 62 (3): 525–563. doi:10.1124/pr.110.002907. ISSN 0031-6997. PMC 2964902.
  2. ^ Chowdhary S, Townend JN (April 2001). "Nitric oxide and hypertension: not just an endothelium derived relaxing factor!". J Hum Hypertens. 15 (4): 219–27. doi:10.1038/sj.jhh.1001165. PMID 11319669.
  3. ^ "Robert Furchgott". Archived from the original on July 3, 2009. Retrieved 2015-03-16.